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Abstract
The EFSA Panel on Genetically Modiﬁed Organisms (GMO) previously assessed the three single events that
are combined to produce the three-event stack oilseed rape (OSR) MS8 3 RF3 3 GT73. In this Scientiﬁc
Opinion, the GMO Panel assessed the three-event stack OSR and subcombinations that have not been
authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73), independently of their origin, for food and
feed uses, import and processing, with the exception of isolated seed protein for food. The combination of
OSR events, MS8, RF3 and GT73, in the three-event stack OSR does not raise issues relating to molecular,
agronomic/phenotypic or compositional characteristics requiring further investigations. In line with
previous assessments and considering the scope of this application, the GMO Panel did not ﬁnd indications
of safety concern for food and feed with trace levels of glyphosate oxidoreductase (GOX)v247 protein
derived from the three-event stack OSR; whereas, the GMO Panel cannot assess the safety of three-event
stack OSR products rich in protein, such as rapeseed protein isolates in feed. As the risk assessment of the
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isolates, the GMO Panel is not in a position to complete the food and feed safety assessment of
subcombinations within the scope of this application (i.e. MS8 3 GT73 and RF3 3 GT73). The two-event
stack OSR MS8 3 RF3 is outside the scope of this application. Considering the scope of this application,
the mode of action of the introduced traits and the data available for the three-event and two-event stack
OSR MS8 3 RF3, the GMO Panel considered that different combinations of the events, MS8, RF3 and
GT73, would not raise environmental concerns.
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Summary
Following the submission of application EFSA-GMO-NL-2009-75 under Regulation (EC) No 1829/20031
from Bayer CropScience AG and Monsanto (referred to hereafter as the applicant), the European Food
Safety Authority (EFSA) Panel on Genetically Modiﬁed Organisms (hereafter referred as GMO Panel)
was asked to deliver a Scientiﬁc Opinion on the safety of genetically modiﬁed glufosinate-ammonium-
and glyphosate-tolerant oilseed rape MS8 3 RF3 3 GT73 (hereafter referred as ‘three-event stack
oilseed rape’) and speciﬁc subcombinations2 (hereafter referred as ‘subcombinations independently of
their origin’ according to the Commission Implementing Regulation (EU) No 503/20133). The scope of
application EFSA-GMO-NL-2009-75 is for the placing on the market of oilseed rape MS8 3 RF3 3 GT73
and subcombinations that have not been authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73),
independently of their origin, for food and feed uses, import and processing, with the exception of
isolated seed protein for food.
The term ‘subcombination’ refers to any combination of two of the events present in the three-
event stack oilseed rape. Subcombinations occur as segregating progeny in the harvested seeds of
oilseed rape MS8 3 RF3 3 GT73 (embryo and albumen), and their safety is evaluated within the
assessment of the three-event stack oilseed rape in Section 4 of the present EFSA GMO Panel Scientiﬁc
Opinion.
‘Subcombination’ also covers combinations of two of the events MS8, RF3 or GT73 that have either
been or could be produced by conventional crossing through targeted breeding approaches. These are
oilseed rape stacks that can be bred, produced and marketed independently of the three-event stack.
These stacks, excluding oilseed rape MS8 3 RF3 that is not in the scope of this application, are risk
assessed in Section 5 of the present EFSA GMO Panel Scientiﬁc Opinion.
In accordance with the EFSA GMO Panel Guidance Document applicable to this application (EFSA,
2007), ‘where all single events have been assessed, the risk assessment of stacked events should
focus mainly on issues related to (a) stability, (b) expression of the events and (c) potential
interactions between the events’. For application EFSA-GMO-NL-2009-75, previous assessments of the
three single events (MS8, RF3 and GT73) and the two-event stack oilseed rape MS8 3 RF3 provided a
basis to evaluate the three-event stack oilseed rape and its subcombinations.
In delivering its Scientiﬁc Opinion, the GMO Panel considered the data available on the three-event
stack oilseed rape and subcombinations, the scientiﬁc comments submitted by the Member States and
the relevant scientiﬁc literature.
The three-event stack oilseed rape was produced by conventional crossing to combine three single
oilseed rape events. The parental oilseed rape lines MS8 (expressing Barnase and phosphinothricin-
acetyl-transferase (PAT) proteins) and RF3 (expressing Barstar and PAT proteins) have been developed
for the production of hybrid seeds MS8 3 RF3 resulting in higher yield due to hybrid vigour. oilseed
rape MS8, RF3 and MS8 3 RF3 were previously assessed all together in respective EFSA GMO
Panel Scientiﬁc Opinions, and no concerns on their safety were identiﬁed. oilseed rape GT73
(expressing glyphosate oxidoreductase (GOX)v247 and CP4 5-enolpyruvylshikimate-3-phosphate
synthase (EPSPS) proteins) was previously assessed by the GMO Panel, and no safety concerns on its
safety were identiﬁed, except for materials rich in protein, such as isolated seed protein, for which an
assessment could not be completed. No safety issue was identiﬁed by the updated bioinformatic
analyses, nor reported by the applicant concerning the three single oilseed rape events, since the
publication of the previous EFSA GMO Panel Scientiﬁc Opinions. Therefore, the GMO Panel considers
that its previous conclusions on the safety of the single events in the context of its assessments (for
oilseed rape GT73, it applies to products with trace levels of GOXv247 protein) remain valid.
For the three-event stack oilseed rape, the risk assessment included the molecular characterisation
of the inserted DNA and analysis of protein expression. An evaluation of the comparative analyses of
agronomic, phenotypic and compositional characteristics was undertaken, and the safety of the newly
expressed proteins and the whole food/feed were evaluated with respect to potential toxicity,
allergenicity and nutritional characteristics. An evaluation of environmental impacts and the
post-market environmental monitoring (PMEM) plan was also undertaken.
1 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modiﬁed
food and feed. Ofﬁcial Journal of the European Communities, L268, p. 1–23.
2 The speciﬁc subcombinations are two-event stacks oilseed rape MS8 3 GT73 and RF3 3 GT73.
3 Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically
modiﬁed food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and
amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006. OJ L 157, 8.6.2013, p. 1–48.
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The molecular data establish that the events stacked in oilseed rape MS8 3 RF3 3 GT73 have
retained their integrity. Protein expression analyses showed some difference between the levels in the
parental lines and the three-event stack which are not unexpected. Therefore, there is no indication of
interaction that may affect the integrity of the events and the levels of the newly expressed proteins in
this stack.
None of the differences identiﬁed in seed composition and agronomic and phenotypic
characteristics between the three-event stack oilseed rape and its conventional counterpart needs
further assessment regarding food and feed safety.
In line with previous assessments, the GMO Panel did not ﬁnd indications of safety concern of the
three-event stack oilseed rape food and feed with trace levels of glyphosate oxidoreductase (GOX)
v247 protein (e.g. oil, pollen, toasted meal). However, the GMO Panel is not in a position to assess the
safety of the three-event stack oilseed rape MS8 3 RF3 3 GT73 rapeseed protein isolates or products
of this nature, as essential data needed for the safety assessment of GOXv247 are lacking. Rapeseed
protein isolates for food is not in the scope of this application. However, products rich in protein, such
as rapeseed protein isolates in animal feeding, are covered by the scope of this application and their
use is emerging.
In the case of accidental release into the environment of viable seeds of the three-event stack
oilseed rape, there are no indications of an increased likelihood of establishment and spread of feral
oilseed rape MS8 3 RF3 3 GT73 plants, or hybridising wild relatives, unless these plants are exposed
to glufosinate-ammonium- and/or glyphosate-containing herbicides. However, the GMO Panel is of the
opinion that the latter will not result in different environmental impacts compared to conventional
oilseed rape. Considering the scope of application EFSA-GMO-NL-2009-75, interactions with the biotic
and abiotic environment were not considered to be a relevant issue. Risks associated with an unlikely
but theoretically possible horizontal gene transfer of recombinant DNA from the three-event stack
oilseed rape to bacteria have not been identiﬁed.
Considering the introduced traits, the outcome of the comparative analysis, the routes of exposure
and limited exposure levels, the GMO Panel concludes that the three-event stack oilseed rape would
not raise safety concerns in the case of accidental release of viable GM oilseed rape seeds into the
environment, irrespective of possible interactions between the individual events within this three-event
stack oilseed rape.
From the three possible subcombinations of oilseed rape MS8 3 RF3 3 GT73, the scope of this
application includes subcombinations that have not been authorised previously (i.e. MS8 3 GT73 and
RF3 3 GT73). The use of oilseed rape MS8 3 RF3 is not in the scope of this application. The risk
assessment of subcombinations takes as starting point the results of the assessment of single events,
data generated for the three-event stack oilseed rape, and all the additional data available on
subcombinations. As the risk assessment of the three-event stack oilseed rape could not be completed
for products rich in protein, such as rapeseed protein isolates in animal feeding, the GMO Panel is not
in a position to complete the safety assessment of subcombinations within the scope of this
application.
Given the absence of safety concerns identiﬁed on the food and feed derived from the three-event
stack oilseed rape MS8 3 RF3 3 GT73 containing trace levels of the GOXv247 protein, the GMO
Panel considers that post-market monitoring of these products is not necessary. However, the GMO
Panel is currently not in a position to formulate any recommendation for a potential post-market
monitoring for rapeseed protein isolates and products of this nature derived from the three-event stack
oilseed rape MS8 3 RF3 3 GT73.
The GMO Panel considers that the scope of the PMEM plans provided by the applicant is consistent
with the scope of the three-event stack oilseed rape and the already assessed two-event stack oilseed
rape MS8 3 RF3. The GMO Panel agrees with the reporting intervals proposed by the applicant in the
PMEM plan.
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Background
On 20 October 2009, the European Food Safety Authority (EFSA) received from the Competent
Authority of the Netherlands application EFSA-GMO-NL-2009-75, for authorisation of genetically modiﬁed
(GM) glufosinate-ammonium- and glyphosate-tolerant oilseed rape MS8 3 RF3 3 GT73 (hereafter
referred as three-event stack oilseed rape), submitted by Bayer CropScience AG and Monsanto (hereafter
referred as the applicant) within the framework of Regulation (EC) No 1829/20031, for food and feed uses,
import and processing. Subsequently, the European Commission asked EFSA to consider a modiﬁcation in
the scope of application EFSA-GMO-NL-2009-75 requested by the applicant. The risk assessment presented
here is for application EFSA-GMO-NL-2009-75 for the placing on the market of genetically modiﬁed
glufosinate-ammonium- and glyphosate-tolerant oilseed rape MS8 3 RF3 3 GT73 and subcombinations
that have not been authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73), independently of their
origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food.
After receiving the application EFSA-GMO-NL-2009-75 and in accordance with Articles 5(2)(b) and
17(2)(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and the European
Commission, and made the summary of the application available to the public on the EFSA website.4
EFSA initiated a formal review of the application to check compliance with the requirements laid down
in Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 29 March 2010, 31 May 2010,
21 September 2010, 18 July 2011, 16 February 2012 and 20 April 2012, EFSA received additional
information (requested on 27 November 2009, 16 April 2010, 6 December 2010, 17 August 2011 and
6 March 2012, respectively). On 11 May 2012, EFSA declared the application valid in accordance with
Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003.
EFSA made the valid application available to the Member States and the European Commission, and
consulted nominated risk assessment bodies of the Member States, including national Competent
Authorities within the meaning of Directive 2001/18/EC5 following the requirements of Articles 6(4) and 18
(4) of Regulation (EC) No 1829/2003, to request their scientiﬁc opinion. The Member States had 3 months
after the date of receipt of the valid application (until 14 May 20136) to make their opinion known.
The EFSA Panel on Genetically Modiﬁed Organisms (GMO) Panel carried out an evaluation of the
scientiﬁc risk assessment of the three-event stack oilseed rape and subcombinations that have not
been authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73) (referred to as ‘subcombinations
independently of their origin’ according to the Commission Implementing Regulation (EU) No 503/
20133). On 2 April 2013, 3 June 2013, 25 June 2013, 6 December 2013, 11 June 2014, 13 February
2015, 17 April 2015, 24 June 2015 and 19 October 2015, the GMO Panel requested additional
information from the applicant. The applicant provided the requested information on 16 May 2013,
2 September 2013, 4 February 2014, 12 September 2014, 4 May 2015, 28 May 2015, 13 August 2015
and 10 November 2015. The applicant provided additional information spontaneously on 16 May 2013,
21 January 2016, 25 January 2016 and 11 March 2016.
In giving its Scientiﬁc Opinion to the European Commission, the Member States and the applicant,
and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has
endeavoured to respect a time limit of 6 months from the acknowledgement of the valid application.
As additional information was requested by the GMO Panel, the time limit of 6 months was extended
accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 1829/2003.
According to Regulation (EC) No 1829/2003, this Scientiﬁc Opinion is to be seen as the report
requested under Articles 6(6) and 18(6) of that Regulation, and thus will be part of the EFSA overall
opinion in accordance with Articles 6(5) and 18(5).
Terms of Reference
In an initial request, the GMO Panel was asked to carry out a scientiﬁc risk assessment of oilseed rape
‘MS8xRF3xGT73 and all sub-combinations of the individual events independently of their origin (as present
in the segregating progeny as well as independent stacks to be placed on the market as such)’, for food
and feed uses, import and processing in accordance with Articles 6(6) and 18(6) of Regulation (EC)
4 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2009-00890
5 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38.
6 The Member States commenting period of application EFSA-GMO-NL-2009-75 was suspended until the clock of the application
was re-started following the adoption of the Scientiﬁc Opinions of applications EFSA-GMO-BE-2010-81 (authorisation of GM
oilseed rape events MS8, RF3, and MS8 3 RF3) and EFSA-GMO-NL-2010-87 (authorisation of GM oilseed rape event GT73).
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No 1829/2003. Subsequently, the European Commission asked EFSA to consider a modiﬁcation in the
scope of application EFSA-GMO-NL-2009-75 requested by the applicant. The risk assessment presented
here is for application EFSA-GMO-NL-2009-75 for the placing on the market of genetically modiﬁed
glufosinate-ammonium- and glyphosate-tolerant oilseed rape MS8 3 RF3 3 GT73 and subcombinations
that have not been authorised previously (i.e. MS8 3 GT73 and RF3 3 GT73), independently of their
origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food.
Where applicable, any conditions or restrictions which should be imposed on the placing on the
market and/or speciﬁc conditions or restrictions for use and handling, including post-market monitoring
requirements based on the outcome of the risk assessment and, in the case of GMOs or food/feed
containing or consisting of GMOs, conditions for the protection of particular ecosystems/environment
and/or geographical areas should be indicated in accordance with Articles 6(5)(e) and 18(5)(e) of
Regulation (EC) No 1829/2003.
The GMO Panel was not requested to give an opinion on information required under Annex II to
the Cartagena Protocol. Furthermore, the GMO Panel did not consider proposals for labelling and
methods of detection (including sampling and the identiﬁcation of the speciﬁc transformation event in
the food/feed and/or food/feed produced from it), which are matters related to risk management.
Assessment
1. Introduction
The application EFSA-GMO-NL-2009-75 covers three events: the three-event stack oilseed rape
MS8 3 RF3 3 GT73 and the two subcombinations that have not been authorised previously (i.e.
MS8 3 GT73 and RF3 3 GT73), independently of their origin (Table 1). The scope of this application
is for food and feed uses, import and processing, with the exception of isolated seed protein for food,
and excludes cultivation within the European Union (EU). The term ‘subcombination’ refers to any
combination of up to two of the events present in the three-event stack oilseed rape. Subcombinations
occur as segregating progeny in harvested seeds of the three-event stack oilseed rape (embryo and
albumen), and their safety is part of the assessment of the three-event stack oilseed rape in Section 4
of this EFSA GMO Panel Scientiﬁc Opinion.
‘Subcombination’ also covers combinations of two of the three events MS8, RF3 or GT73 that have
either been, or could be produced by conventional crossing through targeted breeding approaches
(EFSA GMO Panel, 2011a). These are oilseed rape stacks that can be bred, produced and marketed
independently of the three-event stack oilseed rape. These stacks, except for the two-event stack
oilseed rape MS8 3 RF3 that is not in the scope of this application, are risk assessed in Section 5 of
this EFSA GMO Panel Scientiﬁc Opinion.
The three-event stack oilseed rape was developed to achieve tolerance to the herbicidal active
substances glufosinate-ammonium and glyphosate.
The parental oilseed rape lines MS8 and RF3 have been developed for the production of hybrid
seeds MS8 3 RF3 resulting in higher yield due to hybrid vigour. The oilseed rape events MS8, RF3 and
MS8 3 RF3 have been previously assessed all together in respective EFSA GMO Panel Scientiﬁc
Opinions (see Table 2). No concerns on their safety were identiﬁed by the GMO Panel (Table 2).
The safety of oilseed rape GT73 expressing the GOXv247 protein has been previously considered,
originally under Regulation (EC) No 258/97 (ACNFP Annual Report, 1995), and subsequently by EFSA
GMO Panel in 2004 (EFSA, 2004) and in a renewal opinion in 2009 (EFSA GMO Panel, 2009b). In essence,
these assessments were product-driven, recognising that the GOXv247 was absent in the oil used for
human consumption and was present only in trace amounts in the toasted meal used in animal feeding.
Subsequently, new food products consisting of extracted proteins (protein isolates) from oilseed rape
were assessed (EFSA NDA Panel, 2013). As GOXv247 had the potential to be concentrated in such food
Table 1: Oilseed rape events covered by the scope of the application EFSA-GMO-NL-2009-75
Degree of stacking Events Unique identiﬁers
Three-event stack oilseed rape MS8 3 RF3 3 GT73 ACS-BNØØ5-8xACS-BNØØ3-6xMON-ØØØ73-7
Two-event stacks oilseed rape MS8 3 GT73 ACS-BNØØ5-8xMON-ØØØ73-7
RF3 3 GT73 ACS-BNØØ3-6xMON-ØØØ73-7
oilseed rape: oilseed rape.
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materials and consequently human exposure would have been much greater than from the oil, the GMO
Panel considered that a more extensive toxicological assessment of the protein was necessary in the
context of application EFSA-GMO-NL-2010-87 (EFSA GMO Panel, 2013). To this end, a 28-day toxicity
study in rodents was requested. The applicant argued that such a study was not needed to conﬁrm the
safety of GOXv247 protein7 and did not provide the study. Consequently, the GMO Panel concluded that,
in the absence of consumption data and repeated dose toxicity studies with the GOXv247 protein, it was
not in the position to complete the risk assessment of products of this nature (EFSA GMO Panel, 2013).
The EFSA GMO Panel Guidance Documents establish the principle that ‘where all single events have
been assessed, the risk assessment of stacked events should focus mainly on issues related to (a)
stability, (b) expression of the events and (c) potential interactions between the events’ (EFSA, 2007;
EFSA GMO Panel, 2011a).
2. Issues raised by the Member States
Issues raised by the Member States on the three-event stack oilseed rape were considered in this
EFSA GMO Panel Scientiﬁc Opinion, and are addressed in detail in Annex G of the EFSA Overall Opinion.4
3. Updated information on the events
As the publication of the previous EFSA GMO Panel Scientiﬁc Opinions on the three single oilseed
rape events (EFSA, 2004, 2005; EFSA GMO Panel 2009a,b, 2012, 2013), no safety issue pertaining to
the single events has been reported by the applicant.
Bioinformatic analyses on the junction regions for the events, MS8, RF3 and GT73, using the
methodology speciﬁed in the 2011 EFSA Guidance Document (EFSA GMO Panel, 2011a), conﬁrmed
that no known endogenous genes were disrupted by any of the inserts.8
Updated bioinformatic analyses of the amino acid sequence of the newly expressed
phosphinothricin-acetyl-transferase (PAT), CP4 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS)
and GOXv247 proteins revealed no signiﬁcant similarities to toxins and allergens.8 In addition, updated
bioinformatics analyses of the newly created open reading frames (ORFs) within the inserts and at
their junctions, indicate that the expression of an ORF showing signiﬁcant similarities to toxins or
allergens is highly unlikely.8
In the frame of the present application (EFSA-GMO-NL-2009-75), the GMO Panel requested a
28-day oral toxicity study in rodents with the GOXv247 protein, analytical data on GOXv247 content in
speciﬁc products, as well as an exposure assessment to this protein. The applicant reiterated the view
that a 28-day oral toxicity study was unnecessary to establish the safety of the GOXv247 protein.9 In
addition, the applicant referred to technical difﬁculties in conducting a 28-day study due to
physicochemical properties of the GOXv247 protein.10
Based on the above information, the GMO Panel considers that its previous conclusions on the
safety of the single events in the context of its assessments (for oilseed rape GT73, it applies to
products with trace levels of GOXv247 protein) remain valid. It is noted that the use of protein isolates
in animal feeding is emerging. This issue is considered further in Section 4.3.2.
Table 2: Single oilseed rape events and two-event stacks oilseed rape already assessed by the
GMO Panel
Events Application EFSA GMO Panel Scientiﬁc Opinions
MS8, RF3 and MS8 3 RF3 C/BE/96/01 EFSA (2005)
EFSA-GMO-RX-MS8-RF3 EFSA GMO Panel (2009a)
EFSA-GMO-BE-2010-81 EFSA GMO Panel (2012)
GT73 C/NL/98/11 EFSA (2004)
EFSA-GMO-RX-GT73 EFSA GMO Panel (2009b)
EFSA-GMO-NL-2010-87 EFSA GMO Panel (2013)
GMO: genetically modiﬁed organism.
7 Additional information: 23/4/2012 provided in the context of application EFSA-GMO-NL-2010-87.
8 Additional information: 12/9/2014 and 4/5/2015.
9 Additional information: 2/9/2013 and 12/8/2015.
10 Additional information: 21/1/2016 and 25/1/2016.
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4. Risk assessment of the three-event stack oilseed rape
MS8 3 RF3 3 GT73
4.1. Molecular characterisation
Possible interactions that would affect the integrity of the events, the protein expression level, or
the biological function conferred by the individual inserts are considered below.
4.1.1. Genetic elements and their biological function
Oilseed rape MS8, RF3 and GT73 are combined by conventional crossing to produce the three-
event stack oilseed rape. The structure of the inserts introduced into the three-event stack oilseed
rape is described in detail in previous EFSA Scientiﬁc Opinions, and no new genetic modiﬁcations were
involved. Genetic elements in the expression cassettes of the single events are summarised in Table 3.
Intended effects of the inserts in oilseed rape MS8 3 RF3 3 GT73 are summarised in Table 4.
Table 3: Genetic elements in the expression cassettes of the events stacked in oilseed rape MS8 3
RF3 3 GT73
Event Promoter 50 UTR Transit peptide Coding region Terminator
MS8 Pta29
(Nicotiana
tabacum)(a)
– No barnase
(Bacillus
amyloliquefaciens)
30barnase
(B. amyloliquefaciens),
nos
(Agrobacterium
tumefaciens)
PssuAt
(Arabidopsis
thaliana)
– No bar
(Streptomyces
hygroscopicus)
30g7 (A. tumefaciens)
RF3 Pta29
(N. tabacum)
– No barstar
(B. amyloliquefaciens)
nos (A. tumefaciens)
PssuAt
(A. thaliana)
– No bar (S. hygroscopicus) 30g7 (A. tumefaciens)
GT73 35S
(Figwort mosaic
virus (FMV))
– CTP1
(A. thaliana)
gox247
(Ochrobactrum
anthropi)
E9 (Pisum sativum)
35S (FMV) – CTP2
(A. thaliana)
CP4 epsps
(Agrobacterium sp.
strain CP4)
E9 (P. sativum)
–: when no element was speciﬁcally introduced to optimise expression; CTP: chloroplast transit peptide; UTR: untranslated region.
(a): Source of genetic information.
Table 4: Characteristics and intended effects of the events stacked in oilseed rape MS8 3 RF3 3 GT73
Event Protein
Donor organism and
biological function
Intended effects in GM plant
MS8 Barnase Based on a gene from Bacillus
amyloliquefaciens. Barnase is an
extracellular ribonuclease
secreted by B. amyloliquefaciens
(Hartley, 1988)
In MS8, the barnase coding sequence is under the
control of a speciﬁc promoter (Pta29). It is
only expressed in the tapetum cells during anther
development, and results in male sterility
PAT Based on a gene from
Streptomyces hygroscopicus.
PAT enzyme acetylates
demethylphosphinothricin and
phosphinothricin
(Thompson et al., 1987)
Expression of PAT in oilseed rape MS8 confers
tolerance to glufosinate-ammonium-containing
herbicides
GM oilseed rape MS8 3 RF3 3 GT73 and speciﬁc subcombinations
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Based on known biological function of the newly expressed proteins (Table 4), the only foreseen
interactions at the biological level are between the Barnase and Barstar proteins. The Barnase and
Barstar proteins are expressed in plant tissues (i.e. tapetum cells of the ﬂower buds only) that are not
present in food, or feed derived from the three-event stack oilseed rape.
4.1.2. Integrity of the events in the three-event stack oilseed rape
MS8 3 RF3 3 GT7311
The genetic stability of the inserted DNA over multiple generations in the three single oilseed rape
events was demonstrated previously (see EFSA GMO Panel Scientiﬁc Opinions, Table 2). Southern
analyses demonstrated the integrity of the single events in the F1 generation of the three-event stack
oilseed rape.12
4.1.3. Information on the expression of the inserts13
Plants were grown at three sites (four replicate blocks at each site) under ﬁeld conditions in Canada
in 2011.14 The presence of the Barnase and Barstar proteins is limited to tapetum cells during anther
development. Therefore, an analysis of their levels in other tissues was not considered relevant. The
levels of PAT, CP4 EPSPS and GOXv247 proteins in the three-event stack oilseed rape and the three
single events were quantiﬁed by enzyme-linked immunosorbent assay (ELISA). Protein levels were
Event Protein
Donor organism and
biological function
Intended effects in GM plant
RF3 Barstar Based on a gene from
B. amyloliquefaciens. Barstar
is the speciﬁc intracellular
inhibitor of Barnase which
protects the bacterial cell from
the effects of Barnase
(Hartley, 1988)
In RF3, the barnase coding sequence is under
the control of a speciﬁc promoter (Pta29).
It is only expressed in the tapetum cells, and leads
to restoration of fertility after crossing with the
(MS8)
PAT Based on a gene from
S. hygroscopicus. (PAT)
enzyme acetylates
demethylphosphinothricin
and phosphinothricin
(Thompson et al., 1987)
Expression of PAT in oilseed rape RF3 confers
tolerance to glufosinate-ammonium-containing
herbicides
GT73 GOXv247 Based on a gene from
Ochrobactrum anthropi. The
enzyme glyphosate
oxidoreductase (GOX) catalyses
the conversion of glyphosate to
aminophenyl phosphonate and
glyoxylate (Barry and Kishore,
1994)
GOXv247 confers tolerance to
glyphosate-containing herbicides. GOXv247
expressed in oilseed rape GT73 differs from the
wild type GOX at three amino acid positions.
These substitutions result in improved kinetic
properties of the enzyme
CP4 EPSPS Based on a gene from
Agrobacterium sp. CP4. EPSPS
is an enzyme involved in the
shikimic acid pathway for
aromatic amino acid biosynthesis
in plants and microorganisms
(Herrmann, 1995). Glyphosate
is a competitive inhibitor of this
enzyme
The bacterial CP4 EPSPS confers tolerance to
glyphosate-containing herbicides, as it has a greatly
reduced afﬁnity towards glyphosate as compared
to the plant endogenous enzyme
oilseed rape: oilseed rape; EPSPS: 5-enolpyruvylshikimate-3-phosphate synthase; GM: genetically modiﬁed; PAT:
phosphinothricin-acetyl-transferase.
11 Dossier: Part I – Section D5.
12 Dossier: Part I – Section D2(a).
13 Dossier: Part I – Section D3.
14 Additional information: 2/9/2013.
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determined in leaves (4–6 leaf and early bolt stages), seed and whole above-ground plant. The plants
were treated with glufosinate-ammonium- and/or glyphosate-containing herbicides. Data on seeds
(F2 generation) are reported and discussed below (Table 5).
There are differences between the levels of proteins in seed (F2 generation) produced by the three-
event stack oilseed rape compared to the respective single events. Such differences in expression
levels between parental lines and the stack are not unexpected. Data from greenhouse studies13
suggest that a possible factor explaining the differences in protein expression levels could be the
expected difference in zygosity of the transgenes between the parental lines and the three-event stack
oilseed rape MS8 3 RF3 3 GT73.
4.1.4. Conclusion of the molecular characterisation
The molecular data establish that the events stacked in the three-event stack oilseed rape have
retained their integrity. Protein expression analyses showed some difference between the levels in the
parental lines and the stack which are not unexpected. Therefore, there is no indication of interaction
that may affect the integrity of the events and the levels of the newly expressed proteins in the three-
event stack oilseed rape.
Based on known biological function of the newly expressed proteins, functional interaction between
the Barnase and Barstar proteins are expected. These proteins are expressed in plant tissues (i.e.
tapetum cells of the ﬂower buds only) that are not present in food, or feed derived from the three-
event stack oilseed rape. No functional interaction is expected for the other newly expressed proteins.
Potential interactions are further assessed for their safety implications to human and animals in
Section 4.3, and the environment in Section 4.4.
4.2. Comparative assessment
4.2.1. Choice of comparator and production of material for the comparative
assessment15
Application EFSA-GMO-NL-2009-75 presents data on agronomic and phenotypic characteristics, as
well as on seed composition of the three-event stack oilseed rape derived from ﬁeld trials performed in
Canada in four different growing seasons (Table 6).
The GMO Panel focused on the 2011 ﬁeld trials for the comparative assessment, because they
fulﬁl all the requirements laid down in the GMO Panel Guidance Document for the risk assessment of
food and feed derived from GM plants (EFSA GMO Panel, 2011a). In the 2008 ﬁeld trials, a GM
parental line was used as the comparator. In the 2009 ﬁeld trials, two negative segregants served as
comparators. The GMO Panel is of the opinion that potential unintended differences in the GM plant
owing to the genetic modiﬁcation cannot be discounted using parental lines or negative segregants
as the only comparators (EFSA GMO Panel, 2011a). Therefore, the GMO Panel considers that the
Table 5: Mean and standard deviations (upper row) and ranges (lower row) of protein levels (lg/g
dry weight) in seed from the single oilseed rape events MS8, RF3 and GT73, and oilseed
rape MS8 3 RF3 3 GT73
Protein
Protein levels in seeds
MS8 3 RF3 3 GT73 MS8 RF3 GT73
PAT 0.956 (0.16) 0.632 (0.18) 0.612 (0.15) NA
0.698–1.19 0.419–0.885 0.469–0.916
CP4 EPSPS 11.5 (1.0) NA NA 21.1 (1.9)
9.30–12.9 18.0–24.4
GOXv247 14.0 (2.5) NA NA 26.5 (2.2)
10.3–17.7 22.7–30.3
PAT: phosphinothricin-acetyl-transferase; EPSPS: 5-enoylpyruvyl-shikimate-3-phosphate synthase; GOX: glyphosate oxidoreductase;
NA: not assayed.
15 Dossier: Part I – Section D7.1.
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ﬁeld trials performed in 2008 and 2009 are not appropriate. In the 2010 ﬁeld trials, a conventional
counterpart was used, but natural variation was established using three commercially available GM
oilseed rape lines.
The 2011 ﬁeld trials were performed at eight different locations in the typical summer oilseed rape
growing regions of Canada.18 At each site, the following materials were grown in a randomised
complete block design with four replicates: oilseed rape MS8 3 RF3 3 GT73, the conventional
counterpart19 and three different non-GM oilseed rape reference varieties,20 all treated with required
maintenance pesticides and oilseed rape MS8 3 RF3 3 GT73 treated with the intended herbicides21 in
addition to maintenance pesticides. In these ﬁeld trials, the comparator was a non-GM oilseed rape
line with a genetic background similar to that of oilseed rape MS8 3 RF3 3 GT73 (as documented by
the pedigree) and was therefore considered to be an appropriate conventional counterpart.
The statistical analysis of the agronomic, phenotypic and compositional data from the 2011 ﬁeld
trials followed the recommendations of the GMO Panel (EFSA GMO Panel, 2010a, 2011a). This includes
a test of difference to determine whether the GM plant is different from its conventional counterpart,
and a test of equivalence to determine whether the GM plant falls within the range of natural variation
estimated from the non-GM commercial reference varieties. As described by EFSA (EFSA GMO Panel,
2011a), the result of the equivalence test is categorised into four possible outcomes to facilitate
drawing conclusions with respect to the presence or absence of equivalence. These four categories are
as follows: category I, indicating full equivalence; category II, indicating that equivalence is more likely
than non-equivalence; category III, indicating that non-equivalence is more likely than equivalence;
and category IV, indicating non-equivalence.
4.2.2. Agronomic and phenotypic analysis22
The following nine agronomic and phenotypic endpoints were measured in the in the 2011 ﬁeld
trials (Section 4.2.1): early stand count (establishment), seedling vigour, plant count before and after
herbicide applications, days-to-ﬂowering (measured both at the start and end of ﬂowering: ﬂowering
start and ﬂowering end), plant height, days-to-maturity and seed yield.
No statistically signiﬁcant differences were identiﬁed between the three-event stack oilseed rape
(not treated with the intended herbicides) and its conventional counterpart.
Statistically signiﬁcant differences between the three-event stack oilseed rape treated with the
intended herbicides (in addition to maintenance pesticides) and its conventional counterpart were
observed for ﬂowering end, seed yield and plant height. For the endpoints, ﬂowering end and seed
Table 6: Overview of comparative assessment studies with the three-event stack oilseed rape
MS8 3 RF3 3 GT73 provided in the application EFSA-GMO-NL-2009-75
Study focus Study details Comparators
Commercial
reference varieties
Agronomic and
phenotypic
characteristics;
composition
2008, Canada (ﬁve locations)16 GM parental line
MS8 3 RF3
GM parental lines
MS8 3 RF3 (different
hybrid than the
comparator) and GT73
2009, Canada (three locations)16 Two negative segregants of
MS8 3 RF3 3 GT73
None
2011, Canada (eight locations)17 Conventional counterpart
(line A)
Six non-GM varieties
Composition 2010, Canada (four locations)16 Conventional counterpart Three GM varieties
GM: genetically modiﬁed; GMO: genetically modiﬁed organism; MS8: male sterile line 8.
16 Dossier: Appendices.
17 Dossier: Appendices; additional information: 13/5/2013.
18 Six ﬁeld trials sites were in Saskatchewan (Waldheim, Hague, Radisson, Langham, Maymont and Aberdeen) and two in Alberta
(New Sarepta and Toﬁeld).
19 The conventional counterpart in these ﬁeld trials was a non-GM oilseed rape line with a genetic background comparable with
that of oilseed rape MS8 3 RF3 3 GT73 (as documented by the pedigree).
20 In total, six non-GM commercial oilseed rape reference varieties were included in the ﬁeld trials.
21 Glyphosate- and glufosinate-ammonium-containing herbicides.
22 Dossier: Part I – Section D7.4.
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yield, the test of equivalence indicated that the estimated means and conﬁdence intervals for the
three-event stack oilseed rape were within the equivalence limits from the non-GM oilseed rape
reference varieties (equivalence category I; EFSA GMO Panel, 2011a). For plant height, the test of
equivalence indicated that the estimated mean lies outside the equivalence limits, and that the
conﬁdence interval overlaps with one of the equivalence limits. Hence, non-equivalence for plant
height between the three-event stack oilseed rape and the non-GM oilseed rape reference varieties is
more likely than equivalence (equivalence category III; EFSA GMO Panel, 2011a). Only the observed
difference in plant height is further assessed for its potential environmental impact in Section 4.4.
4.2.3. Compositional analysis23
The seeds from the three-event stack oilseed rape harvested from the ﬁeld trials in Canada in 2011
(Section 4.2.1) were analysed for 81 constituents,24 including the key constituents recommended by
the Organisation for Economic Co-operation and Development (OECD 2011). A total of 21 constituents
having more than 50% of the observations below the limit of quantiﬁcation (LOQ) were excluded from
the statistical analysis.25
The compositional endpoints that are further considered based on the results of the statistical
analysis are presented in Table 7. Statistically signiﬁcant differences between the three-event stack
oilseed rape (not treated with the intended herbicides) and its conventional counterpart were
identiﬁed for 38 compounds in seeds.26 The test of equivalence indicated that 36 of these endpoints
fell under equivalence category I or II, and seed content of cysteine and methionine fell under
equivalence category III (Table 7). Statistically signiﬁcant differences between the three-event stack
oilseed rape (treated with the intended herbicides) and its conventional counterpart were identiﬁed
for 38 compounds in seeds.27 The test of equivalence indicated that 35 of these endpoints fell under
equivalence category
I or II, and seed content of zinc, cysteine and methionine fell under equivalence category III
(Table 7).
After reviewing the biological roles of the compounds in Table 7 and the magnitudes of the changes
observed, the GMO Panel did not identify any need for further assessment with regard to food and
feed safety.
23 Additional information: 13/5/2013.
24 The constituents were: proximates (moisture, crude protein, crude fat, ash, carbohydrates), ﬁbres (neutral detergent ﬁbre,
acid detergent ﬁbre), minerals (iron, zinc, copper, manganese, calcium, magnesium, phosphorus, potassium, sodium),
vitamins (a-, c-, d- and total tocopherols), amino acids (alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine,
histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine), fatty
acids (caproic acid C6:0, caprylic acid C8:0, capric acid C10:0, lauric acid C12:0, myristic acid C14:0, myristoleic acid C14:1,
pentadecanoic acid C15:0, pentadecenoic acid C15:1, palmitic acid C16:0, palmitoleic acid C16:1, heptadecanoic acid C17:0,
heptadecenoic acid C17:1, stearic acid C18:0, oleic acid C18:1, linoleic acid C18:2, linolenic acid C18:3, gamma-linolenic acid
C18:3, arachidic acid C20:0, eicosenoic acid C20:1, eicosadienoic acid C20:2, eicosatrienoic acid C20:3, arachidonic acid
C20:4, behenic acid C22:0, erucic acid C22:1, docosadienoic acid C22:2, lignoceric acid C24:0, nervonic acid C24:1),
glucosinolates (glucoiberin, progoitrin, epi-progoitrin, glucoraphanin, gluconapoleiferin, glucoalyssin, gluconapin,
4-hydroxyglucobrassicin, glucobrassicanapin, glucobrassicin, gluconasturtiin, 4-methoxyglucobrassicin, neoglucobrassicin, total
glucosinolates) and phytic acid.
25 The constituents were: b-tocopherol, glucoiberin, epi-progoitrin, glucoraphanin, gluconapoleiferin, glucoalyssin,
glucobrassicanapin, 4-methoxyglucobrassicin, neoglucobrassicin, caproic acid C6:0, caprylic acid C8:0, capric acid C10:0, lauric
acid C12:0, myristoleic acid C14:1, pentadecanoic acid C15:0, pentadecenoic acid C15:1, gamma-linolenic acid C18:3,
eicosatrienoic acid C20:3, arachidonic acid C20:4, erucic acid C22:1 and docosadieonic acid C22:2.
26 The compounds were: crude protein, crude fat, ash, neutral detergent ﬁbre, acid detergent ﬁbre, carbohydrates, manganese,
calcium, magnesium, potassium, sodium, d-tocopherol, alanine, arginine, cysteine, glutamic acid, glycine, histidine, isoleucine,
leucine, methionine, proline, serine, tryptophan, valine, phytic acid, palmitic acid C16:0, palmitoleic acid C16:1, heptadecanoic
acid C17:0, stearic acid C18:0, oleic acid C18:1, linolenic acid C18:3, arachidic acid C20:0, eicosadienoic acid C20:2, behenic
acid C22:0, lignoceric acid C24:0, nervonic acid C24:1 and gluconapin.
27 The compounds were: crude protein, crude fat, ash, neutral detergent ﬁbre, acid detergent ﬁbre, carbohydrates, manganese,
magnesium, calcium, zinc, d-tocopherol, alanine, arginine, aspartic acid, cysteine, glycine, glutamic acid, histidine, isoleucine,
leucine, methionine, proline, serine, threonine, tryptophan, valine, myristic acid C14:0, palmitic acid C16:0, palmitoleic acid
C16:1, heptadecanoic acid C17:0, stearic acid C18:0, oleic acid C18:1, linoleic acid C18:2, linolenic acid C18:3, arachidic acid
C20:0, behenic acid C22:0, lignoceric acid C24:0 and nervonic acid C24:1.
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4.2.4. Conclusion
The GMO Panel concludes that none of the differences identiﬁed in seed composition and
agronomic and phenotypic characteristics between the three-event stack oilseed rape and its
conventional counterpart needs further assessment regarding food and feed safety.
The difference observed in plant height between the three-event stack oilseed rape and its
conventional counterpart is further assessed for its potential environmental impact in Section 4.4.
4.3. Food and feed safety assessment
4.3.1. Effect of processing28
Based on the outcome of the comparative assessment, processing of the three-event stack oilseed
rape into food and feed products is not expected to result in products being different from those of
commercial non-GM oilseed rape varieties.
4.3.2. Toxicology
4.3.2.1. Toxicological assessment of newly expressed proteins
The three newly expressed proteins in the three-event stack oilseed rape relevant for the food and
feed safety assessment are PAT, CP4 EPSPS and GOXv247 (see Section 4.1.1).
The GMO Panel has previously assessed the safety of these proteins individually in the context of
the single events, and no safety concern was identiﬁed for the PAT and CP4 EPSPS proteins (see
Table 2). Protein expression analyses showed some difference between the levels in the parental lines
and the stack which are not unexpected and do not raise concerns (Section 4.1.4).
The safety of the GOXv247 protein expressed in oilseed rape GT73 has been previously considered
by the GMO Panel, and is described in Section 1 of this Opinion. In the context of this application, the
GMO Panel requested additional information on the GOXv247 protein (see Section 3). However,
essential data needed for the safety assessment of the GOXv247 protein were not provided by the
applicant.8 Taken into account all available information on the safety of GOXv247 protein, a weight-of-
evidence approach could not be followed to sufﬁciently reduce current uncertainties mainly due to the
lack of a 28-day study. Consequently, the GMO Panel cannot assess the safety of products rich in
protein, such as rapeseed protein isolates. Rapeseed protein isolates for food is not in the scope of this
application. However, it is noted that the use products rich in protein, such as rapeseed protein isolates
in animal feeding, is covered by the scope of this application and their use is emerging (e.g. Nagela
et al., 2012; Von Der Haar et al., 2014; http://www.canproingredients.ca/research_development.php).
Table 7: Compositional endpoints that are further discussed based on results of the statistical
analysis: mean (for the conventional counterpart and the three-event stack oilseed rape
MS8 3 RF3 3 GT73) and equivalence limits (from the non-GM oilseed rape reference
varieties) estimated from ﬁeld trials data collected in 2011
Endpoint
Conventional
counterpart
Three-event stack oilseed
rape MS8 3 RF3 3 GT73
Equivalence limits
from non-GM oilseed rape
reference varietiesUntreated(a) Treated(b)
Zinc (mg/kg dw) 47.6 49.4 50.6* (36.9, 47.9)
Cysteine (% dw) 0.494 0.487* 0.488* (0.160, 0.419)
Methionine (% dw) 0.51 0.536* 0.541* (0.447, 0.531)
dw: dry weight; GM: genetically modiﬁed; oilseed rape: oilseed rape.
For the three-event stack oilseed rape, all entries (grey background) fall under equivalence category III; signiﬁcantly different
entries are marked with an asterisk.
(a): Untreated: not sprayed with the intended herbicides.
(b): Treated: sprayed with the intended herbicides.
28 Dossier: Part I – Section D7.6.
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On the basis of the known mode of action of the individual newly expressed proteins, there is no
indication for possible interactions relevant for the food and feed safety assessment of the three-event
stack oilseed rape.
4.3.2.2. Toxicological assessment of components other than newly expressed proteins
The three-event stack oilseed rape did not show any compositional difference to its conventional
counterpart that would require further assessment (see Section 4.2.4). No further food and feed safety
assessment of components other than newly expressed proteins is required.
4.3.3. Animal studies with the food/feed derived from GM plants
No animal studies with the three-event stack oilseed rape were provided by the applicant (e.g. 90-
day toxicity studies in rodents or feeding studies in young rapidly growing animal species).
No substantial modiﬁcations in the composition of the food/feed derived from the three-event stack
oilseed rape (see Section 4.2.4), no indication of possible unintended effects and no interactions were
identiﬁed. Therefore, according to the EFSA Guidance Document (2006a), no animal studies on the
food/feed derived from the three-event stack oilseed rape are required.
4.3.4. Allergenicity
For the allergenicity assessment, a weight-of-evidence approach was followed, taking into account
all of the information obtained on the newly expressed proteins, as no single piece of information or
experimental method yields sufﬁcient evidence to predict allergenicity (EFSA, 2006a; Codex
Alimentarius, 2009; EFSA GMO Panel 2011a). In addition, when known functional aspects of the newly
expressed protein or structural similarity to known adjuvants may indicate an adjuvant activity, the
possible role of these proteins as adjuvants is considered (EFSA GMO Panel, 2011a). When newly
expressed proteins with a potential adjuvant activity are expressed together, possible interactions
increasing adjuvanticity and impacting the allergenicity of the GM crop are assessed.
4.3.4.1. Assessment of allergenicity of the newly expressed proteins29
The GMO Panel has previously evaluated the safety of the PAT, CP4 EPSPS and GOXv247 proteins,
and no concerns on allergenicity were identiﬁed in the context of the previously assessed applications
(e.g. EFSA, 2004, 2005; EFSA GMO Panel 2009a,b, 2012, 2013). No new information on allergenicity
of the single events that might change the previous conclusions of the GMO Panel has become
available. In addition, there is no information available on the structure or function of the individual
newly expressed proteins that would suggest an adverse adjuvant effect of their simultaneous
presence in the three-event stack oilseed rape food and feed.
4.3.4.2. Assessment of allergenicity of GM plant products30
The GMO Panel regularly reviews the available publications on food allergy to oilseed rape (EFSA
GMO Panel, 2014). However, to date, oilseed rape has not been considered to be a common allergenic
food31 (OECD, 2011). Therefore, the GMO Panel did not request experimental data to analyse the
allergen repertoire of GM oilseed rape.
In the context of this application and considering the data from the molecular characterisation, the
compositional analysis and the assessment of the newly expressed proteins (see Sections 4.1 and 4.2),
the GMO Panel identiﬁed no indications of a potentially increased allergenicity of food and feed derived
from the three-event stack oilseed rape compared to that derived from non-GM oilseed.
4.3.5. Nutritional assessment of GM food/feed32
The intended trait of the three-event stack oilseed rape MS8 3 RF3 3 GT73 is herbicide tolerance,
with no intention to alter nutritional parameters. Comparison of nutrients and antinutrients of oilseed
rape MS8 3 RF3 3 GT73 with its conventional counterpart and reference varieties did not identify
29 Dossier: Part I – Section D7.9.1 and additional information 12/9/2014 and 4/5/2015.
30 Dossier: Part I – Section D7.9.2.
31 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to Directive
2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ L 310, 27.11.2007, p. 11–14.
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differences that would require further safety assessment. From these data, an impact on the
nutritional value of food and feed derived from oilseed rape MS8 3 RF3 3 GT73 is not expected.
4.3.6. Conclusion
In line with previous assessments, the GMO Panel did not ﬁnd indications of safety concern of the
three-event stack oilseed rape food and feed with trace levels of GOXv247 protein (e.g. oil, pollen,
toasted meal). However, the GMO Panel is not in a position to assess the safety of the three-event
stack oilseed rape MS8 3 RF3 3 GT73 rapeseed protein isolates or products of this nature, as
essential data needed for the safety assessment of GOXv247 are lacking. Rapeseed protein isolates for
food is not in the scope of this application. However, products rich in protein, such as rapeseed protein
isolates in animal feeding, are covered by the scope of this application and their use is emerging.
4.4. Environmental risk assessment33
The three-event stack oilseed rape has been developed for tolerance to glufosinate-ammonium-
and glyphosate-containing herbicides, and increased heterosis (hybrid vigour) through the use of the
barnase gene, which removes male fertility in order to promote hybridisation, and the barstar gene
which restores male fertility.
The events comprising the three-event stack oilseed rape MS8 3 RF3 3 GT73 have been
previously assessed by the GMO Panel (see Table 2). Therefore, the environmental risk assessment
(ERA) of the three-event stack focused on assessing whether the combination of events, or any
subcombinations interact to present novel hazards and/or routes to exposure as compared to the
single events, the previously assessed two-event stack oilseed rape MS8 3 RF3 and conventional
oilseed rape, and any new risks arising from these potential interactions.
Considering the scope of the application EFSA-GMO-NL-2009-75 (which excludes cultivation), the
ERA of the three-event stack oilseed rape is concerned mainly with: (1) the exposure of bacteria to
recombinant DNA in the gastrointestinal tract of animal fed GM material and bacteria present in
environments exposed to faecal material (manure and faeces); and (2) accidental release into the
environment of imported viable seeds from the three-event stack oilseed rape during transportation
and processing.
4.4.1. Potential unintended effects on plant ﬁtness due to the genetic
modiﬁcation34
Oilseed rape (B. napus AACC) is an allotetraploid species (2n = 38, genome constitution AACC),
which has probably evolved through hybridisation and polyploidisation between the two diploid species
B. rapa (2n = 20, AA) and B. oleracea (2n = 18, CC). It is an annual plant developed for agricultural
production.
Survival of oilseed rape outside cultivation areas is possible. Demographic studies and surveys have
shown the ability of oilseed rape (B. napus) to establish self-perpetuating populations outside
agricultural areas, mainly in seminatural and ruderal habitats in different countries (reviewed by Devos
et al., 2012; Bauer-Panskus et al., 2013; COGEM, 2013; Hecht et al., 2014; Schulze et al., 2014;
Katsuta et al., 2015; Busi and Powles, 2016; Nishizawa et al., 2016). oilseed rape is generally regarded
as an opportunistic species, which can take advantage of disturbed sites (e.g. mowed areas) to
germinate and capture resources rapidly. In undisturbed natural habitats, oilseed rape lacks the ability
to establish stable populations over successive years, possibly due to the absence of competition-free
germination sites (Crawley et al., 1993, 2001) and exposure to biological and abiotic stressors likely
limiting ﬁtness (COGEM, 2013; Busi and Powles, 2016). Once established in competition-free
germination sites, feral populations decline over a period of years (Crawley and Brown, 1995, 2004;
Knispel et al., 2008; Squire et al., 2011; Banks, 2014; Busi and Powles, 2016). However, if habitats are
disturbed on a regular basis, then feral populations can persist for longer periods (Claessen et al.,
2005a,b; Garnier et al., 2006). The persistence or recurrence of a population in one location is
variously attributed to replenishment with fresh seed spills, to recruitment from seed emerging from
the soil seedbank or shed by resident feral adult plants, or to redistribution of feral seed from one
location to another (Pivard et al., 2008a,b).
33 Dossier: Part I – Section D9.
34 Dossier: Part I – Section D9.1 and D9.2.
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The three-event stack oilseed rape has been developed for tolerance to glufosinate-ammonium-
and glyphosate-containing herbicides. The combination of CP4 epsps, gox and pat genes coding for
herbicide tolerance traits can provide a potential agronomic and selective advantage to oilseed rape
MS8 3 RF3 3 GT73 plants when exposed to glufosinate-ammonium- and/or glyphosate-containing
herbicides.
The applicant presented agronomic and phenotypic data on the three-event stack oilseed rape
gathered from ﬁeld trials conducted in oilseed rape growing areas in Canada during several growing
seasons, of which only the 2011 data set allowed a proper agronomic and phenotypic comparison of the
three-event stack oilseed rape with its conventional counterpart (see Section 4.2.2). The 2011 data set
showed reduced plant height for three-event stack oilseed rape plants, for which non-equivalence between
the three-event stack oilseed rape and the non-GM oilseed rape reference varieties is more likely than
equivalence, when treated with the intended herbicides. No relevant differences in the other measured
plant characteristics were identiﬁed (see Section 4.2.2). As ﬁtness is inﬂuenced by the plant’s performance
at various stages of its lifecycle, the observed difference in plant height is unlikely to increase survival,
fecundity, competitiveness or invasiveness characteristics of oilseed rape MS8 3 RF3 3 GT73 plants.
No speciﬁc data were provided to compare seed dormancy of the three-event stack oilseed rape plants
with its conventional counterpart. However, there is no evidence that tolerance to the herbicidal active
substances glufosinate-ammonium or glyphosate would alter seed dormancy of GM herbicide-tolerant
oilseed rape plants, compared to their appropriate comparators. Seed dormancy is more likely to be
affected by the genetic background of parental genotypes than the acquisition of herbicide tolerance traits.
As the general characteristics of the three-event stack oilseed rape remain unchanged compared to
its conventional counterpart, its ability to establish feral populations mostly in ruderal habitats will
remain. Seed import spills can therefore lead to the occurrence of feral oilseed rape
MS8 3 RF3 3 GT73 plants, but these are unlikely to establish stable populations over time (reviewed
by Devos et al., 2012). Should these plants be exposed to glufosinate-ammonium- and/or glyphosate-
containing herbicides, they are likely to exhibit a selective advantage that could increase their
occurrence locally (Londo et al., 2010, 2011; Watrud et al., 2011). However, the likelihood of such an
event to happen will be restricted to herbicide-treated areas with little biodiversity, so that
environmental impacts will be minimal.
Overall, the occurrence of feral oilseed rape MS8 3 RF3 3 GT73 plants resulting from seed import
spills is likely to be low under import conditions, and their occurrence would be conﬁned mostly to
ruderal habitats. These plants will therefore not create additional agronomic or environmental impacts
compared to their conventional counterparts.
4.4.2. Potential for gene transfer35
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic
material, either through horizontal gene transfer of DNA, or through vertical gene ﬂow via the
dispersal of pollen from feral plants originating from spilled seeds.
4.4.2.1. Plant-to-bacteria gene transfer
The potential for horizontal gene transfer of the recombinant DNA of the single oilseed events MS8,
RF3 and GT73, and the two-event stack oilseed rape MS8 3 RF3 was assessed previously by the GMO
Panel. No concern as a result of an unlikely, but theoretically possible, horizontal gene transfer of the
recombinant genes to bacteria in the gut or other receiving environments was identiﬁed (EFSA, 2005;
EFSA GMO Panel, 2009a, 2010b, 2012, 2013). Genes of bacterial origin expressed in the three-event
stack oilseed rape include the CP4 epsps gene of Agrobacterium sp., the gox gene of O. anthropi, the
bar gene of S. hygroscopicus, as well as the barstar and barnase genes of B. amyloliquefaciens,
respectively. No pairs of sequences facilitating double homologous recombination were identiﬁed. As
natural variants of such genes are already present in bacteria occurring in the environment,
homologous recombination and gene replacement will not confer novel properties possibly providing a
selective advantage to members of the natural microbial communities. Synergistic effects of the
recombinant genes in increasing the likelihood for horizontal gene transfer, for instance combinations
of recombinogenic sequences, have not been identiﬁed. As the three-event stack oilseed rape is
produced from conventional crossing, close linkage of the different events is extremely unlikely due to
the distances separating them within the plant genome. Therefore, the GMO Panel concludes that, in
35 Dossier: Part I – Section D9.3.
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the context of the scope of the application EFSA-GMO-NL-2009-75, the unlikely, but theoretically
possible, horizontal transfer of recombinant genes from this three-event stack oilseed rape to bacteria
does not raise any environmental safety concern.
4.4.2.2. Plant-to-plant gene transfer
Considering the scope of the application EFSA-GMO-NL-2009-75 and the biology of oilseed rape, a
possible pathway to harm is the potential of occasional feral GM oilseed rape plants originating from seed
import spills to transfer recombinant DNA to sexually cross-compatible plants. As pointed out above
(Section 4.4.1), the accidental spillage of imported oilseed rape seeds can result in the occurrence of feral
plants often in ruderal and disturbed habitats, where they can survive and reproduce.
Oilseed rape is an open pollinating crop plant capable of cross-pollinating with other Brassica crops
(Eastham and Sweet, 2002). If established adjacent to cross-compatible ﬁeld crops, then feral oilseed
rape MS8 3 RF3 3 GT73 plants arising from spilled seeds could pollinate oilseed rape crop plants.
Shed seed from cross-pollinated crop plants could emerge as GM volunteers in subsequent crops,
although the likelihood of this happening is extremely low under an import scenario (Squire et al.,
2011; Devos et al., 2012).
Oilseed rape can also spontaneously hybridise with sexually compatible wild relatives. Several
oilseed rape 3 wild relative hybrids have been reported in the scientiﬁc literature, but under ﬁeld
conditions transgene introgression has only been conﬁrmed for progeny of oilseed rape 3 B. rapa
hybrids (reviewed by Ellstrand et al., 1999, 2013; FitzJohn et al., 2007; Devos et al., 2009). For
transgene introgression to occur, feral GM oilseed rape must require some overlap in ﬂowering in time
and space with compatible relatives. Subsequently, transgenes must be transmitted through successive
backcross generations or selﬁng, so that they become stabilised into the genome of the recipient (de
Jong and Rong, 2013; Garnier et al., 2014). Because of these barriers (Luijten et al., 2015), reported
incidences of hybrids and backcrosses with B. rapa were therefore found to be low in ﬁelds (Jørgensen
et al., 2004; Norris et al., 2004; Warwick et al., 2008; Elling et al., 2009), or at ports, along roadsides,
and riverbanks (Saji et al., 2005; Aono et al., 2006, 2011; Yoshimura et al., 2006; Elling et al., 2009;
Katsuta et al., 2015; Luijten et al., 2015).
The GMO Panel does not consider the occurrence of occasional feral oilseed rape
MS8 3 RF3 3 GT73 plants, pollen dispersal and consequent cross-pollination as environmental harm
in itself, as there is no evidence that the herbicide tolerance traits will enhance the vertical gene ﬂow
potential, or ﬁtness, persistence or invasiveness of feral oilseed rape MS8 3 RF3 3 GT73, or cross-
compatible plants such as hybridising wild relatives. However, when exposed to glufosinate-
ammonium- and/or glyphosate-containing herbicides, occasional cross-compatible plants that acquired
the herbicide tolerance traits through vertical gene ﬂow are likely to exhibit a selective advantage,
which may lead to their increased occurrence. The likelihood of such an event to happen will be
restricted to herbicide-treated areas, so that environmental impacts will be minimal. Therefore, the
GMO Panel considers that the acquisition of the herbicide tolerance traits by cross-compatible plants
would not create additional agronomic or environmental impacts.
In conclusion, the GMO Panel considers that the likelihood of environmental effects as a
consequence of the spread of genes from the three-event stack oilseed rape in Europe will not differ
from that of conventional oilseed rape varieties, even after exposure to glufosinate-ammonium- and/or
glyphosate-containing herbicides.
4.4.3. Potential interactions of the GM plant with target organisms36
Interactions occasional feral oilseed rape MS8 3 RF3 3 GT73 plants arising from seed import spills
with target organisms are not considered to be a relevant issue by the GMO Panel, as there are no
target organisms.
4.4.4. Potential interactions of the GM plant with non-target organisms37
Considering the scope of the application EFSA-GMO-NL-2009-75, and the low level of exposure to
the environment, potential interactions of occasional feral oilseed rape MS8 3 RF3 3 GT73 plants
arising from seed import spills with non-target organisms are not considered to be a relevant issue by
the GMO Panel.
36 Dossier: Part I – Section D9.4.
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GM oilseed rape MS8 3 RF3 3 GT73 and speciﬁc subcombinations
www.efsa.europa.eu/efsajournal 18 EFSA Journal 2016;14(5):4466
4.4.5. Potential interactions with the abiotic environment and biogeochemical
cycles38
Considering the scope of the application EFSA-GMO-NL-2009-75, and the low level of exposure to
the environment, potential interactions with the abiotic environment and biogeochemical cycles are not
considered to be a relevant issue by the GMO Panel.
4.4.6. Conclusion
In the case of accidental release into the environment of viable seeds of the three-event stack
oilseed rape, there are no indications of an increased likelihood of establishment and spread of feral
oilseed rape MS8 3 RF3 3 GT73 plants, or hybridising wild relatives, unless these plants are exposed
to glufosinate-ammonium- and/or glyphosate-containing herbicides. However, the GMO Panel is of the
opinion that the latter will not result in different environmental impacts compared to conventional
oilseed rape. Considering the scope of the application EFSA-GMO-NL-2009-75, interactions with the
biotic and abiotic environment were not considered to be relevant issues. Risks associated with an
unlikely but theoretically possible horizontal gene transfer of recombinant DNA from the three-event
stack oilseed rape to bacteria have not been identiﬁed.
Considering the novel combination of events, the introduced traits, the outcome of the comparative
analysis, the routes of exposure and the limited exposure levels, the GMO Panel concludes that oilseed
rape MS8 3 RF3 3 GT73 would not raise safety concerns in the event of accidental release of viable
GM oilseed rape seeds into the environment.
4.5. Conclusion on the three-event stack oilseed rape MS8 3 RF3 3 GT73
The combination of oilseed rape events MS8, RF3 and GT73 in the three-event stack oilseed rape
does not raise issues relating to molecular, agronomic/phenotypic or compositional characteristics
requiring further investigations.
In line with previous assessments, the GMO panel did not ﬁnd indications of safety concern of the
three-event stack oilseed rape food and feed with trace levels of GOXv247 protein (e.g. oil, pollen,
toasted meal). However, the GMO Panel cannot assess the safety of the three-event stack oilseed rape
protein isolates or products of this nature as essential data needed for the safety assessment of the
GOXv247 are lacking. Rapeseed protein isolates for food is out of the scope of this application.
However, it is noted that products rich in protein, such as rapeseed protein isolates in animal feeding,
is covered by the scope of this application and its use is emerging.
Considering the introduced traits and the outcome of the comparative analysis, the routes of
exposure and limited exposure levels, the GMO Panel concludes that the three-event stack oilseed rape
would not raise safety concerns in the event of accidental release of viable GM oilseed rape seeds into
the environment.
5. Risk assessment of the subcombinations
The risk assessment of subcombinations (see Table 1) takes as starting point the results of the
assessment of the single events, data generated for the three-event stack oilseed rape, and all the
additional data available on subcombinations. As the risk assessment of the three-event stack oilseed
rape could not be completed for products rich in protein, such as rapeseed protein isolates in animal
feeding, the GMO Panel is not in a position to complete the safety assessment of subcombinations
within the scope of this application.
6. Post-market monitoring
6.1. Post-market monitoring of GM food/feed39
Given the absence of safety concerns identiﬁed on the food and feed derived from the three-event
stack oilseed rape MS8 3 RF3 3 GT73 containing trace levels of the GOXv247 protein, the GMO
Panel considers that post-market monitoring of these products is not necessary. However, the GMO
38 Dossier: Part I – Section D9.8 and D9.10.
39 Dossier: Part I – Section D7.11.
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Panel is currently not in a position to formulate any recommendation for a potential post-market
monitoring for rapeseed protein isolates and products of this nature derived from the three-event stack
oilseed rape MS8 3 RF3 3 GT73.
6.2. Post-market environmental monitoring40
The objectives of a post-market environmental monitoring (PMEM) plan according to Annex VII of
Directive 2001/18/EC are: (1) to conﬁrm that any assumption regarding the occurrence and impact of
potential adverse effects of the GMO, or its use, in the ERA are correct; and (2) to identify the
occurrence of adverse effects of the GMO, or its use, on human health or the environment that were
not anticipated in the ERA.
Monitoring is related to risk management, and thus a ﬁnal adoption of the PMEM plan falls outside
the mandate of EFSA. However, the GMO Panel gives its opinion on the scientiﬁc content of the PMEM
plan provided by the applicant (EFSA, 2006b; EFSA GMO Panel, 2011b).
As the ERA did not identify potential adverse environmental effects from the three-event stack
oilseed rape and one of its stacks, no case-speciﬁc monitoring is required.
The PMEM plans proposed by the applicant for the three-event stack oilseed rape include: (1) the
description of an approach involving operators (federations involved in oilseed rape import and
processing), reporting to the applicant, via a centralised system, any observed adverse effect(s) of
GMOs on human health and the environment; (2) a coordinating system newly established by
EuropaBio for the collection of the information recorded by the various operators; and (3) the use of
networks of existing surveillance systems (Lecoq et al., 2007; Windels et al., 2008). The applicant
proposes to submit a PMEM report on an annual basis.
The GMO Panel considers that the scope of the PMEM plans provided by the applicant is consistent
with the scope of the three-event stack oilseed rape and the already assessed two-event stack oilseed
rape MS8 3 RF3. The GMO Panel agrees with the reporting intervals proposed by the applicant in the
PMEM plans. However, the post-market environmental plan submitted by the applicant for the three-
event stack oilseed rape does not include any provision for the two- event stacks not previously
assessed by the GMO Panel.
In addition, the GMO Panel acknowledges the approach proposed by the applicant to put in place
appropriate management systems to restrict environmental exposure in the case of accidental release
of viable seeds of oilseed rape MS8 3 RF3 3 GT73.
Should risk managers consider the control of feral oilseed rape plants desirable, then the
implementation of appropriate communication means for the timely reporting of control failures of feral
oilseed rape populations may be recommended.
Overall conclusions and recommendations
The GMO Panel considers that its previous conclusions on the safety of the single oilseed rape
events, MS8, RF3 and GT73, in the context of its assessments (for oilseed rape GT73 it applies to
products with trace levels of GOXv247 protein) remain valid.
The combination of oilseed rape events MS8, RF3 and GT73 in the three-event stack oilseed rape
does not raise issues relating to molecular, agronomic/phenotypic or compositional characteristics
requiring further investigations.
In line with previous assessments, the GMO panel did not ﬁnd indications of safety concern of the
three-event stack oilseed rape food and feed with trace levels of GOXv247 protein (e.g. oil, pollen,
toasted meal). However, the GMO Panel is not in a position to assess the safety of the three-event
stack oilseed rape MS8 3 RF3 3 GT73 rapeseed protein isolates or products of this nature, as
essential data needed for the safety assessment of GOXv247 are lacking. Rapeseed protein isolates for
food is not in the scope of this application. However, products rich in protein, such as rapeseed protein
isolates in animal feeding, are covered by the scope of this application and its use is emerging.
From the three possible subcombinations of oilseed rape MS8 3 RF3 3 GT73, the scope of this
application includes subcombinations that have not been authorised previously (i.e., MS8 3 GT73
and RF3 3 GT73). The use of oilseed rape MS8 3 RF3 is not in the scope of this application. The
risk assessment of subcombinations takes as starting point the results of the assessment of the
single events, the data generated for the three-event stack oilseed rape, and all the additional data
40 Dossier: Part I – Section D9.11.
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available on subcombinations. As the risk assessment of the three-event stack oilseed rape could not
be completed for products rich in protein, such as rapeseed protein isolates in animal feeding, the
GMO Panel is not in a position to complete the safety assessment of subcombinations within the
scope of this application.
Considering the introduced traits and the outcome of the comparative analysis, the routes of
exposure and limited exposure levels, the GMO Panel concludes that the three-event stack oilseed rape
would not raise safety concerns in case of accidental release of viable GM oilseed rape seeds into the
environment, irrespective of possible interactions between the individual events within this three-event
stack oilseed rape. There are no indications of an increased likelihood of spread and establishment of
feral oilseed rape MS8 3 RF3 3 GT73 plants, or hybridising wild relatives, unless these plants are
exposed to glufosinate-ammonium- and/or glyphosate-containing herbicides. Moreover, in the light of
the scope of the application, data available for various subcombinations, the GMO Panel is of the
opinion that any subcombinations of the individual events, including those not previously assessed by
EFSA, would raise no environmental safety concerns.
Given the absence of safety concerns identiﬁed on the food and feed derived from the three-event
stack oilseed rape MS8 3 RF3 3 GT73 containing trace levels of the GOXv247 protein, the GMO
Panel considers that post-market monitoring of these products is not necessary. However, the GMO
Panel is currently not in a position to formulate any recommendation for a potential post-market
monitoring for rapeseed protein isolates and products of this nature derived from the three-event stack
oilseed rape MS8 3 RF3 3 GT73.
The GMO Panel considers that the scope of the PMEM provided by the applicant is consistent with
the scope of the three-event stack oilseed rape and the already assessed two-event stack oilseed rape
MS8 3 RF3. The GMO Panel agrees with the reporting intervals proposed by the applicant in the
PMEM plans.
Documentation as provided to EFSA
1) Letter from the Competent Authority of the Netherlands, received on 20 October 2009,
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GM oilseed rape MS8 3 RF3 3 GT73 and speciﬁc subcombinations
www.efsa.europa.eu/efsajournal 21 EFSA Journal 2016;14(5):4466
15) Letter from EFSA to applicant dated 6 December 2010 requesting additional information
under completeness check.
16) Letter from applicant to EFSA received on 24 January 2011 providing the timeline for submission
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on single events (application EFSA-GMO-BE-2010-81 and EFSA-GMO-NL-2010-87).
28) Letter from EFSA to applicant dated 25 January 2013 re-starting the clock due to the
ﬁnalisation of the assessment of applications EFSA-GMO-BE-2010-81 and EFSA-GMO-NL-
2010-87.
29) Letter from EFSA to applicant dated 2 April 2013 requesting additional information and stopping
the clock.
30) Letter from applicant to EFSA received on 16 May 2013 providing additional information
requested and spontaneous supplementary information.
31) Letter from EFSA to applicant dated 3 June 2013 requesting additional information and
maintaining the clock stopped.
32) Letter from EFSA to applicant dated 25 June 2013 requesting additional information and
maintaining the clock stopped.
33) Letter from applicant to EFSA received on 17 July 2013 providing the timeline for submission of
responses.
34) Letter from applicant to EFSA received on 1 August 2013 extending the timeline for submission
of responses.
35) Letter from applicant to EFSA received on 2 September 2013 providing additional information.
36) Letter from applicant to EC dated 10 September 2013 requesting a change on the scope of
the application.
37) Letter from EFSA to applicant dated 6 December 2013 requesting additional information
and maintaining the clock stopped.
38) Letter from applicant to EFSA received on 20 January 2014 providing the timeline for
submission of responses.
39) Letter from applicant to EFSA received on 4 February 2014 providing additional information.
40) Letter from EFSA to applicant dated 11 June 2014 requesting additional information and
maintaining the clock stopped.
41) Letter from applicant to EFSA received on 25 July 2014 providing the timeline for submission of
responses.
42) Letter from applicant to EFSA received on 12 September 2014 providing additional information.
43) Letter from applicant to EFSA received on 9 January 2015 asking clariﬁcations on the progress of
the application.
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44) Letter from EFSA to applicant dated 10 February 2015 providing clariﬁcations on the progress of
the application.
45) Letter from EFSA to applicant dated 13 February 2015 requesting additional information and
maintaining the clock stopped.
46) Letter from EFSA to applicant dated 17 April 2015 requesting additional information and
maintaining the clock stopped.
47) Letter from applicant to EFSA received on 4 May 2015 providing additional information.
48) Letter from EFSA to applicant dated 17 April 2015 requesting additional information and
maintaining the clock stopped.
49) Letter from applicant to EFSA received on 28 May 2015 providing additional information.
50) Letter from applicant to EC dated 11 June 2015 requesting a modiﬁcation of the scope of
the application.
51) Letter from EFSA to applicant dated 24 June 2015 requesting additional information and
maintaining the clock stopped.
52) Letter from applicant to EC received on 13 August 2015 providing further clariﬁcations on
the scope of the application.
53) Letter from applicant to EFSA received on 13 August 2015 providing additional information.
54) Letter from EFSA to applicant dated 19 October 2015 requesting additional information and
maintaining the clock stopped.
55) Letter from applicant to EFSA received on 10 November 2015 providing additional
information.
56) Letter from EFSA to applicant dated 19 January 2016 re-starting the clock.
57) Letter from applicant to EFSA received on 21 January 2016 providing additional information
spontaneously.
58) Letter from EC to EFSA received on 22 January 2016 regarding the scope of the application.
59) Letter from applicant to EFSA received on 25 January 2016 providing additional information.
60) Letter from EFSA to EC dated 28 January 2016 regarding the scope of the application.
61) E-mail from EFSA to applicant dated 18 February 2016 requesting updated additional
information.
62) Letter from applicant to EFSA received on 29 February 2016 regarding clariﬁcations on the scope
of the application.
63) Letter from applicant to EFSA received on 11 March 2016 providing updated additional
information following the modiﬁcation of the scope of the application.
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ELISA enzyme-linked immunosorbent assay
EPSPS 5-enolpyruvylshikimate-3-phosphate synthase
ERA environmental risk assessment
GM genetically modiﬁed
GMO genetically modiﬁed organism
GOX glyphosate oxidoreductase
OECD Organisation for Economic Co-operation and Development
ORF open reading frame
PAT phosphinothricin acetyltransferase
PMEM post-market environmental monitoring
UTR untranslated region
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